Dedicating to cross-border pharma and health-care related projects' BD partnership building (including but not limited in the licensing-in/out, Co-development, NewCO, JV as well as venture capital investment etc), as well as the solution provider for the innovative drug and medtical treatment products' market access into China or other other global markets.